The applicability of this general method has been extended to synthesize an array of novel 3,5-diarylpyrazole derivatives (15); some of these are potent acetylcholinesterase inhibitors possessing excellent selectivity, and have been accepted as prospective drug candidates for treating Alzheimer’s disease (Scheme 8) [13]. This evidence concerns the gene ACHE and Alzheimer disease.